Homeostatic chemokine receptors and organ-specific metastasis

@article{Zlotnik2011HomeostaticCR,
  title={Homeostatic chemokine receptors and organ-specific metastasis},
  author={Albert Zlotnik and Amanda M. Burkhardt and Bernhard Homey},
  journal={Nature Reviews Immunology},
  year={2011},
  volume={11},
  pages={597-606}
}
It has been 10 years since the role of a chemokine receptor, CXCR4, in breast cancer metastasis was first documented. Since then, the field of chemokines and cancer has grown significantly, so it is timely to review the progress, analyse the studies to date and identify future challenges facing this field. Metastasis is the major factor that limits survival in most patients with cancer. Therefore, understanding the molecular mechanisms that control the metastatic behaviour of tumour cells is… 
The role of the chemokine receptor CCR7 in cancer progression
TLDR
A review of relevant perspectives on the functional mechanisms and prognostic significance of CCR7, the receptor for both chemokines CCL19 and CCL21, in cancer and the mechanisms underlying these functions remain unclear.
Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
TLDR
This work focuses on the relevant chemokine/chemokine receptor axes that have been described to drive the metastatic process and elaborate on their role in the regulation of tumor angiogenesis and immune cell recruitment at both the primary tumor lesions and the pre-metastatic foci.
Role of Chemokines and Chemokine Receptors in Cancer
TLDR
The mechanism through which chemokines control the different stages of oncogenesis is described and their role in the modulation of specific and innate immune responses against the tumor, along with their impact on the tumor prognosis is discussed.
The Role of Chemokine Receptors CCR6 and CCR7 in the Initiation and Progression of Breast Cancer
TLDR
A small, pioneering body of evidence for the potentially important function of the “immuniche” in maintaining and supporting breast cancer stem cells is summarized.
Chemokine Regulation of Cell Trafficking in Lung Cancer Metastasis
TLDR
Emerging preclinical data on the efficacy of CXCR4 inhibitors suggests that CX CR4 should be explored as a clinical target for blocking metastatic progression in lung cancer.
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.
TLDR
The role of chemokines is emphasized in the process of metastasis and metastatic heterogeneity, and understanding the interplay between chemokine-chemokine receptor networks between the tumor cells and their microenvironment is a novel approach to overcome the problem of metastatics heterogeneity.
The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression
TLDR
This review summarizes the essential roles of C-C Chemokine receptor 7 and its receptors in breast cancer progression and discusses the mechanisms of regulation that may lead to novel opportunities for therapeutic intervention.
Migration, Metastasis, and More: The Role of Chemokines in the Proliferation, Spreading, and Metastasis of Tumors
TLDR
Their role in various steps of tumor progression, in particular with regard to tumor cells, tumor stem cells, the tumor microenvironment, tumor angiogenesis, and the spreading/metastasis of tumors is outlined.
...
...

References

SHOWING 1-10 OF 142 REFERENCES
Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4
TLDR
The role of a synthetic antagonist 14-mer peptide (TN14003) in inhibiting metastasis of breast cancer by inhibiting migration is investigated and may prove useful as a diagnostic tool to identify CXCR4 receptor-positive tumor cells in culture and tumors in paraffin-embedded clinical samples.
CXCR4 and cancer
TLDR
Interestingly, cancer stem cells also express CXCR4, indicating that the CX CR4‐SDF‐1 axis may direct the trafficking and metastasis of these cells to organs that express high levels of SDF‐ 1, such as the lymph nodes, lungs, liver, and bone.
The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
TLDR
It is demonstrated that human prostate cell lines derived from metastases express functional CXCR4 receptor and that CXCL12 ligand enhances their migratory capabilities.
Potential of CXCR4 antagonists for the treatment of metastatic lung cancer
TLDR
Data is summarized about the cellular and molecular microenvironment in small-cell lung cancer and non-small- cell lung cancer, as well as the role of CXCR4 in tumor–stroma crosstalk, and the current status of the preclinical and clinical development of CxCR4 antagonists.
Involvement of chemokine receptors in breast cancer metastasis
TLDR
It is reported that the chemokine receptors CXCR4 and CCR7 are highly expressed in human breast cancer cells, malignant breast tumours and metastases and their respective ligands CXCL12/SDF-1α and CCL21/6Ckine exhibit peak levels of expression in organs representing the first destinations of breast cancer metastasis.
Multiple functions of CXCL12 in a syngeneic model of breast cancer
TLDR
Therapies that boost CXCL12 levels at the primary tumor site may prove more effective in the treatment of metastatic breast cancer, and the need to consider carefully therapeutic strategies that block CxCL12 signaling is highlighted.
Chemokines in tumor-associated angiogenesis
TLDR
The pharmacologic control of tumor angiogenesis presents a promising strategy for novel anticancer therapeutics and is highlighted in the context of chemokines and their receptors.
CXCR4 mediates the proliferation of glioblastoma progenitor cells.
...
...